Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of USD Additional Tier 1 Securities

30 Jul 2015 07:01

RNS Number : 5060U
Royal Bank of Scotland Group PLC
30 July 2015
 



THE ROYAL BANK OF SCOTLAND GROUP PLC

The Royal Bank of Scotland Group plc to issue USD denominated Additional Tier 1 securities

30 July 2015

The Royal Bank of Scotland Group plc ("RBSG") intends, subject to market conditions, to issue securities that qualify as Additional Tier 1 capital under Capital Requirements Directive IV (2013/36/EU) and the Capital Requirements Regulation (575/2013) ("CRD IV / CRR"). The intended issuance is expected to further strengthen RBSG's capital base.

The intended issuance will be in the form of USD denominated Perpetual Subordinated Contingent Convertible Additional Tier 1 Capital Notes (the "Contingent Capital Notes"). The Contingent Capital Notes will be subject to full conversion into ordinary shares of RBSG in the event its CET1 capital ratio falls below 7.0% (the "Conversion Trigger Event").

The offer price, initial coupon, conversion price and final amount of the Contingent Capital Notes sold will be determined at the conclusion of the offering process and will be announced in a separate press release. There will be no adjustment to the conversion price of RBSG's B shares upon issuance of the Contingent Capital Notes. Instead, a determination as to whether such adjustment is necessary will be made following a Conversion Trigger Event, if applicable, based on the price of RBSG's ordinary shares at that time.

Any offering of Contingent Capital Notes will be made pursuant to RBSG's registration statement on Form F-3 which became immediately effective upon filing with the U.S. Securities and Exchange Commission ("SEC").

RBS Securities Inc. has been appointed as Global Co-ordinator and Structuring Advisor, Joint Bookrunner and Joint Lead Manager and Credit Suisse Securities (USA) LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. LLC have been appointed as Joint Bookrunners and Joint Lead Managers.

 

For further information:

 

RBS Investor Relations

Matthew Richardson

Head of Debt Investor Relations

Tel: +44 (0) 20 7678 1800

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements that include the words "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBSG's future economic results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBSG's actual results are discussed in RBSG's UK Annual Report and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBSG's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBSG does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

The securities referred to in this press release are not intended to be sold and should not be sold to retail clients in the European Economic Area, as defined in the rules set out in the Temporary Marketing Restriction (Contingent Convertible Securities) Instrument 2014 or the Product Intervention (Contingent Convertible Instruments and Mutual Society Shares) Instrument 2015 (together, the "MR Rules"), as amended or replaced from time to time, other than in circumstances that do not and will not give rise to a contravention of those rules by any person.

 

Notice to U.S. persons: The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in the registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the issuer or any underwriter participating in the offering will arrange to send you the prospectus if you request it by calling RBS Securities Inc. toll-free at 1-866-884-2071, calling Credit Suisse Securities (USA) LLC toll-free at 1-800-221-1037, contacting Merrill Lynch, Pierce, Fenner & Smith Incorporated at 222 Broadway, New York, NY 10038, Attn: Prospectus Department (email: dg.prospectus_requests@baml.com) and calling Morgan Stanley & Co. LLC toll-free at 1-866-718-1649.

 

Notice to U.K. persons: This communication has not been approved by an authorized person for the purposes of section 21 of the Financial Services and Markets Act 2000 (as amended) ("FSMA"). Accordingly, this communication is only for distribution to and directed at: (i) in the United Kingdom, persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") and high net worth entities falling within Article 49(2)(a) to (d) of the Order; (ii) persons who are outside the United Kingdom; and (iii) any other person to whom it can otherwise be lawfully distributed (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this communication relates is available only to and will be engaged in only with Relevant Persons. Persons who are not Relevant Persons should not take any action based upon this communication and should not rely on it. 

 

Other Jurisdictions Outside the United States: No action may be taken in any jurisdiction other than the United States that would permit a public offering of the securities referred to in this press release or the possession, circulation or distribution of this document or the prospectus in any jurisdiction where action for that purpose is required. Accordingly, such securities may not be offered or sold, directly or indirectly, and neither this document, the prospectus nor any other offering material or advertisements in connection with such securities may be distributed or published in or from any country or jurisdiction, except under circumstances that will result in compliance with any applicable rules and regulations of any such country or jurisdiction.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEADXNAEDSEAF
Date   Source Headline
30th Nov 20167:03 amRNSStatement re 2016 stress test results
22nd Nov 20163:35 pmRNSDividend Declaration
22nd Nov 20162:55 pmRNSPublication of Suppl.Prospcts
16th Nov 20166:00 pmRNSAllotment and Issue of New Ordinary Shares
9th Nov 20163:01 pmRNSDirector/PDMR Shareholding
8th Nov 20167:00 amRNSRBS Launches a New Complaints Process
31st Oct 20163:40 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSInterim Management Statement
6th Oct 20164:15 pmRNSBlock listing Interim Review
30th Sep 20161:37 pmRNSTotal Voting Rights
30th Sep 20167:00 amRNSProposed Future Ring Fenced Structure and Brands
28th Sep 20167:00 amRNSRBS Settles Certain RMBS Claims with the NCUA
27th Sep 20168:30 amRNSBank of America Merrill Lynch CEO Conference
12th Sep 20162:30 pmRNSBarclays Global Financial Services Conference
8th Sep 20167:00 amRNSRBSG priced $2.65 billion Senior Notes
2nd Sep 20165:44 pmRNSAllotment and Issue of new Ordinary shares
31st Aug 20162:43 pmRNSTotal Voting Rights
25th Aug 20167:02 amRNSDividend Declaration
25th Aug 20167:00 amRNSRedemption of USD Preference Shares Series R and T
23rd Aug 20163:00 pmRNSDirector/PDMR Shareholding
19th Aug 20162:15 pmRNSPublication of Suppl.Prospcts
11th Aug 20167:00 amRNSRBSG successfully priced $2.65bn Additional Tier
8th Aug 20163:30 pmRNSDirector/PDMR Shareholding
5th Aug 20167:00 amRNSHalf Year Report - Part 2
5th Aug 20167:00 amRNSHalf Year Report - Part 1
1st Aug 20167:07 amRNS2016 EBA EU-wide stress test results
29th Jul 20163:18 pmRNSTotal Voting Rights
21st Jul 20161:15 pmRNSVocaLink Holdings Limited Shareholding
30th Jun 20161:18 pmRNSTotal Voting Rights
29th Jun 20161:36 pmRNSHolding(s) in Company
27th Jun 20165:12 pmRNSDividend Declaration
24th Jun 201612:02 pmRNSPrice Monitoring Extension
9th Jun 20168:00 amRNSGoldman Sachs European Financials Conference
7th Jun 20165:30 pmRNSPublication of a Prospectus
1st Jun 20165:25 pmRNSNotification of Major Interest in Shares
31st May 20163:17 pmRNSTotal Voting Rights and Capital changes
26th May 20165:15 pmRNSDividend Declaration
24th May 20165:56 pmRNSAllotment and Issue of New Ordinary Shares
16th May 201610:00 amRNSAppointment of a Non-Executive Director
16th May 20167:07 amRNSNotices of Redemption
11th May 20163:39 pmRNSDirector/PDMR Shareholding
10th May 201612:40 pmRNSNotices of Redemption
4th May 20165:45 pmRNSResult of AGM
4th May 20161:55 pmRNSAGM Statement
29th Apr 20162:17 pmRNSTotal Voting Rights and Capital changes
29th Apr 20167:00 amRNSInterim Management Statement
28th Apr 20165:41 pmRNSRBS Holdings N.V. and Royal Bank of Scotland N.V.
28th Apr 20161:55 pmRNSUpdate on the disposal of Williams & Glyn
26th Apr 20164:04 pmRNSDividend Declaration
20th Apr 20163:03 pmRNSForm 8.3 - Electronic Data Processing plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.